National Health (Pharmaceutical benefits – early supply) Amendment Instrument 2021 (No. 5) (Cth)

PB 47 of 2021

National Health (Pharmaceutical benefits – early supply) Amendment Instrument 2021
(No. 5)

National Health Act 1953

___________________________________________________________________________

I, NIKOLAI TSYGANOV, Assistant Secretary (Acting), Pricing and PBS Policy Branch, Technology Assessment and Access Division, Department of Health, delegate of the Minister for Health and Aged Care, make this Instrument under subsection 84AAA(2) of the National Health Act 1953.

Dated         27 May 2021

NIKOLAI TSYGANOV

Assistant Secretary (Acting)

Pricing and PBS Policy Branch

Technology Assessment and Access Division

Department of Health

___________________________________________________________________________

1. Name of Instrument

(1)This Instrument is the National Health (Pharmaceutical benefits – early supply) Amendment Instrument 2021 (No. 5).

(2)This Instrument may also be cited as PB 47 of 2021.

1. Commencement

This Instrument commences on 1 June 2021.

1. Amendment of National Health (Pharmaceutical benefits—early supply) Instrument 2015 (PB 120 of 2015)

Schedule 1 amends the National Health (Pharmaceutical benefits—early supply) Instrument 2015 (PB 120 of 2015).

Schedule 1       Amendments

1. Schedule 1, entry for Adalimumab

substitute:

Adalimumab	Injection 20 mg in 0.2 mL pre-filled syringe	20	2	0
20	2	3
20	2	5
Injection 20 mg in 0.4 mL pre‑filled syringe	20	2	0
20	2	3
20	2	5
Injection 40 mg in 0.4 mL pre-filled pen	20	2	0
20	2	2
20	2	5
20	4	5
20	6	0
Injection 40 mg in 0.4 mL pre-filled syringe	20	2	0
20	2	2
20	2	5
20	6	0
Injection 40 mg in 0.8 mL pre‑filled pen	20	2	0
20	2	2
20	2	5
20	4	5
20	6	0
Injection 40 mg in 0.8 mL pre‑filled syringe	20	2	0
20	2	2
20	2	5
20	6	0
Injection 80 mg in 0.8 mL pre-filled pen	20	2	5
20	3	0
Injection 80 mg in 0.8 mL pre-filled syringe	20	2	5
20	3	0

1. Schedule 1, after entry for Baricitinib in the form Tablet 4 mg

insert:

Beclometasone with formoterol and glycopyrronium Pressurised inhalation containing beclometasone dipropionate 100 micrograms with formoterol fumarate dihydrate 6 micrograms and glycopyrronium 10 micrograms (as bromide) per dose, 120 doses 20 1 5

1. Schedule 1, after entry for Galantamine in the form Capsule (prolonged release) 24 mg (as hydrobromide)

insert:

Galcanezumab	Injection 120 mg in 1 mL pre-filled pen	20	1	5
20	2	1